Company intelligence / Profile preview
US Biologic
Memphis, Tennessee, United Statesusbiologic.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
US Biologic has developed an orally delivered wildlife Lyme disease vaccine (Borrelia burgdorferi bacterin) that is integrated into the commercial LymeShield System for environmental Lyme control and is working with BARDA/DRIVe on an oral influenza vaccine and with USDA and DHS partners on multiple oral vaccines and antibiotic alternatives in animals; its programs are largely in pre-clinical and field-deployment stages rather than formal human clinical trial phases.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineDNA vaccineBiologic
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) Division of Research, Innovation, and Ventures (DRIVE)U.S. Department of Agriculture Agricultural Research Service (ARS)U.S. Department of Homeland Security Plum Island Animal Disease Center Science & Technology DirectorateUniversity of EdinburghJP McHale Pest Management (commercial LymeShield deployment partner)Global Lyme AllianceCenter for Lyme Action
Beyond the preview
Go deeper on US Biologic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on US Biologic.